Global Enteric Disease Testing market is expected to reach USD 5.05 billion by 2030, at a CAGR of3% from 2021 to 2030. Implementation of stringent laws related to contaminant identification, expansion in consumer awareness, and humid atmospheric conditions, which are contributing to an increase in food contamination, are driving the growth of the enteric disease testing market.
Microorganisms that cause intestine illnesses like viruses, parasites and bacteria cause enteric diseases. These diseases are usually caused by consuming contaminated water or food, and some of them can be passed from person to person.Intestinal infections can be caused by bacteria, viruses, and parasites such as shigella,salmonella, campylobacter, cryptosporidium,giardia lamblia, and vibrio cholera. Bacteria that enter the body through the mouth or intestine cause shigellosis, salmonella, giardiasis, cryptosporidiosis, campylobacteriosis, and cholera. Enteric illnesses are characterized by vomiting,nausea, stomach cramps, diarrhea, chills, fever, and a loss of appetite. Enteric bacteria have been identified as one of the main causative species of water and foodborne diseases.All-around world, hemolytic uremic syndrome, and diarrhea (HUS) is growing more widespread. The most common cause is enteric bacterial infections. Due to factors such as rising diarrhea prevalence, rising prevalence in emerging nations, increased government awareness, and different government and public sector activities, the enteric disease testing market is likely to grow throughout the forecast period.
Get an overview of this study by requesting a free sample
Convenience and packaged food goods, such as frozen foods and ready-to-eat (RTE) meals, have gradually shifted consumer focus away from traditional raw food purchases. Additives are used to enhance the organoleptic properties of food and beverages to increase marketability. Preservatives are also added to packaged goods to extend their shelf life. The demand for enteric disease testing is increasing as people's preferences for convenience foods increase.
Over the forecast period, rising fatalities from bacterial enteric illnesses could support industrial growth. Every year, millions of individuals are infected with enteric diseases all over the world, but they are most common in developing countries with poor sanitation. As a result of poor sanitation, a large portion of the population in nations like India and Brazil suffers from diarrheal enteric infections. This situation benefits the industry's growth by increasing demand for enteric disease testing, which leads to higher industry growth.
The food business in developing nations is still highly fragmented, dominated by small and unorganised firms who may not have adopted proper food testing procedures, increasing the danger of contamination. Food and beverage product testing, such as packaged foods, dairy products, beverages, and meat products, necessitates appropriate enforcement mechanisms, market stakeholder coordination, and supporting infrastructure. Many nations in the developing economies cluster, on the other hand, lack these factors, posing a barrier to pathogen testing in food and water in these regions.
Demand for enteric disease testing is predicted to rise because of enteric disease research and development. For example, studies conducted by Bangladesh's International Centre for Diarrhoeal Disease Research and Emory University in the United States found a high concentration of pathogens such as E. coli, norovirus, Vibrio cholerae, shigella, Salmonella typhi, and giardia in Bangladesh in April 2017-January 2018.
Automated testing instruments are more expensive since they have more advanced features and functions. For some end users, the estimated cost of the instrument, media, and labour is also very high. Many of these systems are required in testing laboratories, resulting in a large rise in the overall capital cost investment.
The global enteric disease testing market has been segmented based on test type, disease type and regions.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region emerged as the largest market for the global Enteric Disease Testing market with a 32.2%share of the market revenue in 2020.
North America Region Enteric Disease Testing Market Share in 2020 - 32.2%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances, and partnerships to improve their market position in the global enteric disease testing industry.
SGS announced the launch of its new food testing laboratory in Papua New Guinea in June 2021, which will provide internationally recognised quality testing to the food manufacturing, hospitality, and retail markets.
For example, in March 2019, The Saliva-based Malaria Asymptomatic and Asexual Rapid Test, developed by ERADA Technology Alliance Ltd. (ERADA), is a saliva-based diagnostic method for detecting parasites which cause malaria.
As per The Brainy Insights, the size of the enteric disease testing market was valued at USD 3.76 Billion in 2020 to USD 5.05 Billion by 2030.
Global enteric disease testing market is growing at a CAGR of 3% during the forecast period 2021-2030.
The global enteric disease testing market has been segmented based on test type, disease type, and regions. The molecular diagnostics segment is expected to dominate the global market over the forecast period.
North America region emerged as the largest market for the enteric disease testing.
The market's growth will be influenced by demand for convenience foods.
In developing economies, there are no effective regulations guiding pathogen testing, this could hamper the market growth.
R&D in enteric diseases will provide huge opportunities to the market.
Key players are3M, ALS Limited, AsureQuality, Becton Dickinson, Bio-Rad Laboratories, Inc., Bureau Veritas, Certified Laboratories, Eurofins Scientific, Hardy Diagnostics, Intertek, Merck KGaA, Mérieux NutriSciences, Neogen Corporation, Nova Biologicals
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis ByTest Type
4.3.2. Market Attractiveness Analysis ByDisease Type
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Demand for convenience foods is on the rise
5.2.2. Rising deaths from bacterial enteric diseases
5.3. Restraints
5.3.1. In developing economies, there are no effective regulations guiding pathogen testing
5.4. Opportunities
5.4.1. R&D in enteric diseases
5.5. Challenges
5.5.1. Food and water testing has a high cost associated with it
6. Global Enteric Disease Testing Market Analysis and Forecast, By Test Type
6.1. Segment Overview
6.2. Immunoassay Testing
6.3. Molecular Diagnostic Testing
6.4. Conventional Testing
7. Global Enteric Disease Testing MarketAnalysis and Forecast, By Disease Type
7.1. Segment Overview
7.2. Bacterial Enteric Disease
7.3. Parasitic Enteric Disease
7.4. Viral Enteric Disease
8. Global Enteric Disease Testing Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Enteric Disease Testing Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in GlobalEnteric Disease Testing Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. 3M
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. ALS Limited
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. AsureQuality
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Becton Dickinson
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Bio-Rad Laboratories, Inc.
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Bureau Veritas
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Certified Laboratories
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Eurofins Scientific
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Hardy Diagnostics
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Intertek
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. Merck KGaA
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. Mérieux NutriSciences
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
10.13. Neogen Corporation
10.13.1. Business Overview
10.13.2. Company Snapshot
10.13.3. Company Market Share Analysis
10.13.4. Company Product Portfolio
10.13.5. Recent Developments
10.13.6. SWOT Analysis
10.14. Nova Biologicals
10.14.1. Business Overview
10.14.2. Company Snapshot
10.14.3. Company Market Share Analysis
10.14.4. Company Product Portfolio
10.14.5. Recent Developments
10.14.6. SWOT Analysis
10.15. PerkinElmer Inc.
10.15.1. Business Overview
10.15.2. Company Snapshot
10.15.3. Company Market Share Analysis
10.15.4. Company Product Portfolio
10.15.5. Recent Developments
10.15.6. SWOT Analysis
10.16. Romer Labs
10.16.1. Business Overview
10.16.2. Company Snapshot
10.16.3. Company Market Share Analysis
10.16.4. Company Product Portfolio
10.16.5. Recent Developments
10.16.6. SWOT Analysis
10.17. SGS SA
10.17.1. Business Overview
10.17.2. Company Snapshot
10.17.3. Company Market Share Analysis
10.17.4. Company Product Portfolio
10.17.5. Recent Developments
10.17.6. SWOT Analysis
10.18. Symbio Laboratories
10.18.1. Business Overview
10.18.2. Company Snapshot
10.18.3. Company Market Share Analysis
10.18.4. Company Product Portfolio
10.18.5. Recent Developments
10.18.6. SWOT Analysis
10.19. Thermo Fisher Scientific Inc.
10.19.1. Business Overview
10.19.2. Company Snapshot
10.19.3. Company Market Share Analysis
10.19.4. Company Product Portfolio
10.19.5. Recent Developments
10.19.6. SWOT Analysis
10.20. TÜV SÜD
10.20.1. Business Overview
10.20.2. Company Snapshot
10.20.3. Company Market Share Analysis
10.20.4. Company Product Portfolio
10.20.5. Recent Developments
10.20.6. SWOT Analysis
List of Table
1. Global Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
2. Global Immunoassay TestingEnteric Disease TestingMarket, By Region, 2018–2030 (USD Billion)
3. Global Molecular Diagnostic TestingEnteric Disease TestingMarket, By Region, 2018–2030 (USD Billion)
4. Global Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
5. GlobalBacterial Enteric DiseaseEnteric Disease Testing Market, By Region, 2018–2030 (USD Billion)
6. Global Parasitic Enteric DiseaseEnteric Disease Testing Market, By Region, 2018–2030 (USD Billion)
7. Global Viral Enteric Disease Enteric Disease Testing Market, By Region, 2018–2030 (USD Billion)
8. Global Enteric Disease Testing Market, By Region, 2018–2030 (USD Billion)
9. Global Enteric Disease Testing Market, By North America, 2018–2030 (USD Billion)
10. North America Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
11. North America Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
12. U.S. Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
13. U.S. Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
14. Canada Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
15. Canada Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
16. Mexico Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
17. Mexico Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
18. Europe Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
19. Europe Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
20. Germany Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
21. Germany Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
22. France Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
23. France Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
24. U.K. Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
25. U.K. Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
26. Italy Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
27. Italy Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
28. Spain Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
29. Spain Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
30. Asia Pacific Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
31. Asia Pacific Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
32. Japan Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
33. Japan Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
34. China Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
35. China Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
36. India Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
37. India Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
38. South America Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
39. South America Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
40. Brazil Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
41. Brazil Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
42. Middle East and Africa Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
43. Middle East and Africa Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
44. UAE Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
45. UAE Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
46. South Africa Enteric Disease Testing Market, By Test Type, 2018–2030 (USD Billion)
47. South Africa Enteric Disease Testing Market, By Disease Type, 2018–2030 (USD Billion)
List of Figures
1. Global Enteric Disease Testing Market Segmentation
2. Enteric Disease Testing Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Enteric Disease Testing MarketAttractiveness Analysis ByTest Type
9. Global Enteric Disease Testing MarketAttractiveness Analysis ByDisease Type
10. Global Enteric Disease Testing MarketAttractiveness Analysis By Region
11. Global Enteric Disease Testing Market: Dynamics
12. Global Enteric Disease Testing MarketShare ByTest Type (2021&2030)
13. Global Enteric Disease Testing MarketShare ByDisease Type(2021&2030)
14. Global Enteric Disease Testing MarketShare by Regions (2021&2030)
15. Global Enteric Disease Testing MarketShare by Company (2020)
This study forecasts revenue at global, regional, and country levels from 2018 to 2030. The Brainy Insights has segmented the global enteric disease testing market based on below mentioned segments:
Global Enteric Disease Testing Market by Test Type:
Global Enteric Disease Testing Market by Disease Type:
Global Enteric Disease Testing Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date